Education
About Us
Working with TipRanks
Follow Us
Thermo Fisher (DE:TN8)
XETRA:TN8
TN8 Stock Chart & Stats
Day’s Range― - ―
52-Week Range€336.25 - €590.90
Previous CloseN/A
Volume2.00
Average Volume (3M)245.00
Market Cap
$134.66B
Enterprise Value€180.25B
Total Cash (Recent Filing)$5.95B
Total Debt (Recent Filing)$34.19B
Price to Earnings (P/E)22.5
Beta0.64
Next Earnings
Jul 23, 2025EPS Estimate
4.46Last Dividend Ex-Date
Jun 13, 2025Dividend Yield0.39%
Share Statistics
EPS (TTM)4.39
Shares Outstanding377,493,930
10 Day Avg. Volume245
30 Day Avg. Volume245
Financial Highlights & Ratios
PEG Ratio7.51
Price to Book (P/B)3.05
Price to Sales (P/S)0.00
P/FCF Ratio22.34
Enterprise Value/Market Cap1.34
Enterprise Value/Revenue1.06
Enterprise Value/Gross Profit10.11
Enterprise Value/Ebitda4.04
Forecast
1Y Price Target
$466.03Price Target Upside27.16% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering19
Thermo Fisher News
Bulls Say, Bears Say
Bulls Say
Financial PerformanceThe revised deal is estimated to be accretive by approximately 24 cents pre-financing costs, which is seen as an incremental positive.
Investment PlanTo support long-term growth and expand market share, TMO announced plans to invest US$2bn over the next four years in expanding its US manufacturing and R&D facilities, in response to growing customer demand.
Strategic InitiativesIf successful, this transaction could streamline Thermo Fisher Scientific's operations and focus on other growth areas.
Bears Say
EPS GuidanceThe company revised its adjusted EPS guidance downward, expecting a range from a 0.6% decline to 4.4% growth, mainly due to the impact of tariffs.
Profit MarginsSOLV expects that holding onto the water business will reduce prior gross margin/operating margin benefits post-close, suggesting lower margins for the Drinking Water Filtration business.
Revenue UncertaintyThe divestment includes parts of the diagnostics business that generate significant sales, leading to uncertainty about the impact on TMO's revenue.
Options Prices
Currently, No data available
---
Ownership Overview
0.12% Insiders
24.33%
Mutual Funds
27.75% Other Institutional Investors
27.88% Public Companies and Individual Investors
TN8 FAQ
What was Thermo Fisher’s price range in the past 12 months?
Thermo Fisher lowest stock price was €336.25 and its highest was €590.90 in the past 12 months.
What is Thermo Fisher’s market cap?
Thermo Fisher’s market cap is $134.66B.
When is Thermo Fisher’s upcoming earnings report date?
Thermo Fisher’s upcoming earnings report date is Jul 23, 2025 which is in 14 days.
How were Thermo Fisher’s earnings last quarter?
Thermo Fisher released its earnings results on Apr 23, 2025. The company reported €4.394 earnings per share for the quarter, beating the consensus estimate of €4.352 by €0.042.
Is Thermo Fisher overvalued?
According to Wall Street analysts Thermo Fisher’s price is currently Undervalued.
Does Thermo Fisher pay dividends?
Thermo Fisher pays a Quarterly dividend of €1.396 which represents an annual dividend yield of 0.39%. See more information on Thermo Fisher dividends here
What is Thermo Fisher’s EPS estimate?
Thermo Fisher’s EPS estimate is 4.46.
How many shares outstanding does Thermo Fisher have?
Thermo Fisher has 377,493,930 shares outstanding.
What happened to Thermo Fisher’s price movement after its last earnings report?
Thermo Fisher reported an EPS of €4.394 in its last earnings report, beating expectations of €4.352. Following the earnings report the stock price went up 4.668%.
Which hedge fund is a major shareholder of Thermo Fisher?
Currently, no hedge funds are holding shares in DE:TN8
Thermo Fisher Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$466.03 (27.16% Upside)
$466.03 (27.16% Upside)
Blogger Sentiment
Bullish
DE:TN8 Sentiment 83%
Sector Average 71%
Sector Average 71%
News Sentiment
Very Bullish
Bullish news 99%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-19.58%
12-Months-Change
Fundamentals
Return on Equity
13.73%
Trailing 12-Months
Asset Growth
2.00%
Trailing 12-Months
Company Description
Thermo Fisher
Thermo Fisher Scientific Inc. provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services in the North America, Europe, Asia-Pacific, and internationally. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as diagnosis of infections and diseases; and solutions include biosciences, genetic sciences, and bio production to pharmaceutical, biotechnology, agricultural, clinical, healthcare, academic, and government markets. Its Analytical Instruments segment provides instruments, consumables, software, and services for pharmaceutical, biotechnology, academic, government, environmental, and other research and industrial markets, as well as clinical laboratories. The company's Specialty Diagnostics segment offers liquid, ready-to-use, and lyophilized immunodiagnostic reagent kits, as well as calibrators, controls, protein detection assays, and instruments; immunodiagnostics develops, manufactures and markets complete bloodtest systems to support the clinical diagnosis and monitoring of allergy, asthma and autoimmune diseases; dehydrated and prepared culture media, collection and transport systems, instrumentation, and consumables; human leukocyte antigen typing and testing for organ transplant market; and healthcare products. Its Laboratory Products and Biopharma Services segment provides laboratory products, research and safety market channel, and pharma services and clinical research. It offers products and services through a direct sales force, customer-service professionals, electronic commerce, and third-party distributors under Thermo Scientific; Applied Biosystems; Invitrogen; Fisher Scientific; Unity Lab Services; and Patheon and PPD. Thermo Fisher Scientific Inc. was founded in 1956 and is headquartered in Waltham, Massachusetts.
TN8 Earnings Call
Q1 2025
0:00 / 0:00
Earnings Call Sentiment|Neutral
The earnings call highlighted strong financial performance and strategic initiatives in innovation and M&A. However, significant challenges were noted due to macroeconomic conditions, US-China tariffs, and pressures in the academic and government markets.Read More>TN8 Revenue Breakdown
54.01% Laboratory Products and Biopharma Services
22.46% Life Sciences Solutions
17.40% Analytical Instruments
10.52% Specialty Diagnostics
TN8 Stock 12 Month Forecast
Average Price Target
€466.03
▲(27.16%Upside)